Déclaration d'accessibilité Sauter la navigation
  • Ressources
  • Journalistes
  • Relations investisseurs
  • Webdiffusion
  • English
  • mon CNW 
    • Ouvrir une session
    • Créez un compte
  • Ouvrir une session
  • Inscription
  • Envoyer
Cision Canada
  • Nouvelles
  • Produits
  • Nous joinder
Recherche
When typing in this field, a list of search results will appear and be automatically updated as you type.

Rechercher votre contenu...

Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

News Releases

view all
    Recherche avancée
    • Communiqués
        • Parcourir les communiqués

        • Tous les communiqués de presse
        • Tous les communiqués de sociétés publiques
        • Parcourir tous les communiqués

        • Galerie multimédia

        • Tous les communiqués avec multimédia
        • Tous les communiqués avec photos
        • Tous les communiqués avec vidéos
        • Voir toute la Galerie multimédia

        • Sujets d'actualité

        • Voir tous les sujets d'actualité
    • Affaires
        • Affaires Générales

        • Activités d'externalisation
        • Annonces relatives au personnel
        • Communiqués salon professionnel
        • Enquêtes, sondages et recherches
        • Expansion d'entreprise
        • Immobilier commercial
        • Immobilier résidentiel
        • Investissement socialement responsable
        • Licenciement
        • Nécrologie
        • Nouveaux produits et services
        • Récompenses
        • Ressources humaines et gestion des effectifs
        • Résultats financiers
        • Services aux petites entreprises
        • Transactions immobilières
        • Survol, Affaires Générales

        • Voir tout Affaires Générales

        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Secteur de l’automobile et du transport

        • Aérospatiale, défense
        • Automobile
        • Chaîne logistique / Logistique
        • Compagnies aériennes & Aviation
        • Fret aérien
        • Maritime & Construction navale
        • Tourisme et Voyages
        • Transport, camionnage et de chemin de fer
        • Transports routiers
        • Voies ferrées et transport intermodal
        • Survol, Secteur de l’automobile et du transport

        • Voir tout Secteur de l’automobile et du transport

        • Services financiers et investissements

        • Accords financiers
        • Acquisitions, fusions et rachats
        • Activisme actionnarial
        • Annonces de conférence de presse
        • Assurance
        • Capital de risque
        • Coentreprises
        • Contrats
        • Cryptomonnaie
        • Dividendes
        • Émission d'actions
        • Faillite
        • Fonds communs
        • Fractionnement d'actions
        • Immobilier
        • Nouvelles et dossiers
        • Obligations et actions
        • Opinions d'investissement
        • Placement privé
        • Prévisions de résultats & projections
        • Rapports des ventes
        • Restructuration & recapitalisation
        • Résultats financiers
        • Services bancaires & financiers
        • Survol, Services financiers et investissements

        • Voir tout Services financiers et investissements

        • Technologies des affaires

        • Analyse de données
        • Automatisation de la conception électronique
        • Chaîne de blocs
        • Commerce électronique
        • Composants électroniques
        • Informatique et électronique
        • Logiciel informatique
        • Matériel informatique
        • Nanotechnologie
        • Périphériques
        • Réseaux
        • Sécurité haute technologie
        • Semi-conducteurs
        • Technologie de radiodiffusion
        • Technologie financière
        • Technologie Internet
        • Survol, Technologies des affaires

        • Voir tout Technologies des affaires

    • Sciences et technologie
        • Énergie et ressources naturelles

        • Chimie
        • Commodités
        • Découvertes en matière de pétrole et de gaz
        • Énergies alternatives
        • Fabrication générale
        • Gaz
        • Mines
        • Mines & Métaux
        • Pétrole & Énergie
        • Services d'eau
        • Services d'électricité
        • Survol, Énergie et ressources naturelles

        • Voir tout Énergie et ressources naturelles

        • Environnement

        • Catastrophes naturelles
        • Conservation & Recyclage
        • Politique environnementale
        • Problèmes environnementaux
        • Produits et services environnementaux
        • Technologie verte
        • Survol, Environnement

        • Voir tout Environnement

        • Industries lourdes et manufacturières

        • Aéronautique & Défense
        • Agriculture
        • Chimie
        • Construction & Bâtiment
        • CVC (Chauffage, ventilation et climatisation)
        • Fabrication générale
        • Machinerie
        • Machines-outils, travail des métaux et métallurgie
        • Métaux précieux
        • Mine
        • Mines & Métaux
        • Papier, produits forestiers et conteneurs
        • Tabac
        • Textiles
        • Survol, Industries lourdes et manufacturières

        • Voir tout Industries lourdes et manufacturières

        • Technologie de consommation

        • Analyse de données
        • Chaîne de blocs
        • Chaîne logistique / Logistique
        • Commerce électronique
        • Communications sans fil
        • Cryptomonnaie
        • Divertissement mobile
        • Électronique de consommation
        • Infonuagique / Internet des objets
        • Informatique et électronique
        • Intelligence artificielle
        • Jeux électroniques
        • Logiciel informatique
        • Matériel informatique
        • Médias sociaux
        • Multimédia & Internet
        • Périphériques
        • STIM (Science, technologie, ingénierie, mathématiques)
        • Technologie financière
        • Survol, Technologie de consommation

        • Voir tout Technologie de consommation

        • Télécommunications

        • Carrières et services
        • Communications sans fil
        • Divertissement mobile
        • Équipement de télécommunication
        • Industrie de la télécommunication
        • Périphériques
        • Réseaux
        • VoIP (voix sur IP)
        • Survol, Télécommunications

        • Voir tout Télécommunications

    • Santé et style de vie
        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Produits de consommation et vente au détail

        • Aliments biologiques
        • Aliments et boissons
        • Animaux et animaux domestiques
        • Bières, vins et spiritueux
        • Bijoux
        • Boissons
        • Boissons non-alcoolisées
        • Cannabis
        • Commerce
        • Jouets
        • Ménages, Consommateurs, Cosmétiques
        • Meubles et ameublement
        • Mode
        • Produits cosmétiques et soins personnels
        • Produits d'entretien domestique
        • Produits de bureau
        • Rappels de produit
        • Rénovation domiciliaire
        • Restaurants
        • Services nuptiaux
        • Supermarchés
        • Survol, Produits de consommation et vente au détail

        • Voir tout Produits de consommation et vente au détail

        • Santé

        • Approbation médicale internationale
        • Assurance santé
        • Biométrique
        • Biotechnologie
        • Conditionnement physique / Mieux-être
        • Contrôle des infections
        • Dentisterie
        • Équipement médical
        • Essais cliniques & de Découvertes Médicales
        • Homologation de la FDA
        • Médecines complémentaires
        • Pharmaceuticals médicaux
        • Pharmaceutiques
        • Santé mentale
        • Soins de santé & hôpitaux
        • Survol, Santé

        • Voir tout Santé

        • Sports

        • Équipements et accessoires de sport
        • Événements sportifs
        • Plein air, camping, randonnée pédestre
        • Sports en général
        • Survol, Sports

        • Voir tout Sports

        • Tourisme et Voyages

        • Hôtels et stations
        • Hôtels et stations
        • Industrie du voyage
        • Loisirs et tourisme
        • Parcs d'attraction et attractions touristiques
        • Plein air, camping, randonnée pédestre
        • Trafic aérien de passagers
        • Survol, Tourisme et Voyages

        • Voir tout Tourisme et Voyages

    • Politique et intérêt public
        • Politique et intérêt public

        • Actualités, tendances, analyses économiques
        • Actualités syndicales
        • Bien-être de l'animal
        • But non lucratif
        • Catastrophes naturelles
        • Direction & Agence fédérale exécutif
        • Éducation
        • Environnement
        • Gouvernement européen
        • Homologation de la FDA
        • Législation fédérale et nationale
        • Opinion du groupe de défense des droits
        • Politique commerciale
        • Politique étrangère
        • Politique fédérale
        • Politique intérieure
        • Politique municipale
        • Politique provinciale
        • Questions juridiques
        • Responsabilité sociale de l'entreprise
        • Sécurité intérieure
        • Sécurité publique
        • Survol, Politique et intérêt public

        • Voir tout Politique et intérêt public

    • Société
        • Société

        • Actualités liées aux Afro-américains
        • Actualités liées aux Asiatiques
        • Actualités liées aux enfants
        • Actualités liées aux femmes
        • Actualités liées aux personnes handicapées
        • Actualités orientées vers les hispaniques
        • Anciens combattants
        • Autochtones, Premières Nations et Amérindiens
        • Diversité, équité & inclusion
        • Intérêt des hommes
        • Lesbienne, Homosexuel, Bisexuel
        • Personnes du troisième âge
        • Religion
        • Survol, Société

        • Voir tout Société

    • Recherche avancée
    • Découvrir la plateforme
    • Planifier des campagnes
    • Créer avec l'IA
    • Diffuser des communiqués
    • Mesurer vos résultats
    • Amplifier le contenu
    • Devenir un client
    • Demandez une démo
    • Bureaux d'édition
    • Partenariats
    • Renseignements généraux
    • Médias
    • Bureaux Mondiaux
    • Hamburger menu
    • Cision Canada
    • Envoyer
    • EN
      • Téléphone

      • 877-269-7890 de 8h00 à 22h00

      • Contactez Cision
      • Contactez Cision

        877-269-7890
        de 8h00 à 22h00

    • Rechercher votre contenu...

      Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

      News Releases

      view all
      Close menu
    • Nouvelles
    • Produits
    • Nous joinder
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • 3 Communiqués
      • 5 Affaires
      • 5 Sciences et technologie
      • 5 Santé et style de vie
      • 1 Politique et intérêt public
      • 1 Société
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Découvrir la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifier le contenu
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Devenir un client
      • Demandez une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux Mondiaux
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      Close submenu (Communiqués) Communiqués
      • Parcourir les communiqués
      • Galerie multimédia
      • Sujets d'actualité
      Close submenu (Affaires) Affaires
      • Affaires Générales
      • Divertissement et médias
      • Secteur de l’automobile et du transport
      • Services financiers et investissements
      • Technologies des affaires
      Close submenu (Sciences et technologie) Sciences et technologie
      • Énergie et ressources naturelles
      • Environnement
      • Industries lourdes et manufacturières
      • Technologie de consommation
      • Télécommunications
      Close submenu (Santé et style de vie) Santé et style de vie
      • Divertissement et médias
      • Produits de consommation et vente au détail
      • Santé
      • Sports
      • Tourisme et Voyages
      Close submenu (Politique et intérêt public) Politique et intérêt public
      • Politique et intérêt public
      Close submenu (Société) Société
      • Société

      Dialogue Health Technologies Reports Fourth Quarter and Full Year 2021 Results

      Dialogue Logo (CNW Group/Dialogue Health Technologies Inc.)

      Nouvelles fournies par

      Dialogue Health Technologies Inc.

      23 mars, 2022, 07:00 ET

      Partager cet article

      Partager cet article


      Record Quarter Highlighted by a $9.6 Million Increase in ARR, an Expansion in Gross Margin to 43.5%, and the Addition of iCBT to Our Partnership with Canada Life

      MONTREAL, March 23, 2022 /CNW Telbec/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"), Canada's premier health and wellness virtual healthcare platform, announced today its financial and operational results for the three months and year ended December 31, 2021. Financial references are in Canadian dollars unless otherwise indicated.

      "2021 was a pivotal year for Dialogue as we made our entry on the Toronto Stock Exchange. Even more notably, we delivered strong growth, launched our Integrated Health PlatformTM, strengthened our offering with the addition of internet-based cognitive behavioural therapy, and expanded our largest partnerships," said Cherif Habib, Chief Executive Officer of Dialogue. "As we enter 2022, we are excited about the opportunity to take advantage of our growing scale, competitive moats, and market awareness to establish Dialogue as the leading, fully-integrated virtual health and wellness platform in Canada and beyond."

      Navaid Mansuri, Chief Financial Officer, added: "We are pleased with our record fourth quarter performance, as we demonstrated excellent revenue growth and continued business efficiencies, ending 2021 on a high note. Our business model is scaling, and we saw sustained momentum across our key operating metrics. Our IPO has allowed us to strengthen our balance sheet, positioning us well to make purposeful acquisitions to enhance our offering. We will continue executing on our strategy as we focus on the large, long-term growth opportunity ahead of us."

      Q4 2021 Financial Highlights

      (All capitalized terms not defined herein, shall have the meaning and usefulness ascribed to them in the Management's Discussion and Analysis for the three months and year ended December 31, 2021 Comparison periods in each case are the three months and year ended December 31, 2020, unless otherwise stated)

      • Annual Recurring and Reoccurring Revenue ("ARR") grew 45.2% year-over-year to $85.0 million, driven by new Customer wins, which include a national retailer of general merchandise, a national home improvement company, a global IT and business consulting services firm, and a large Canadian labour union, as well as program expansions and the addition of new services by existing Customers.
      • Fourth quarter revenue increased by 40.6% year-over-year to $18.9 million, due to growth in Members, both Direct and from agreements with strategic distribution partners, and an increase in the Attach Rate as existing Customers add more services over time.
      • Members grew to more than 1.8 million, an increase of more than 900,000, or 98.0%, year-over-year, and approximately 82,000, or 4.7%, compared to the third quarter of 2021. Many signed customers chose to launch our platform at the start of 2022, subsequent to quarter end, to account for budgetary and financial planning requirements. As such, we onboarded an additional 100,000 members in the first week of 2022. When factoring the timing of these additions, Members grew approximately 182,000, or 10.3%, compared to the third quarter of 2021.
      • Attach Rate grew to 1.50 from 1.07 in the same period last year, mainly due to the addition of our internet-based cognitive and behavioural therapy ("iCBT") service to The Canada Life Assurance Company's ("Canada Life") Consult+ platform.
      • Member-Service Units, which we define as total Members multiplied by the Attach Rate, rose 177.6% year-over-year to just under 2.8 million from approximately 1.0 million in the same period last year. This meaningful increase demonstrates the success of Dialogue's land and expand strategy, as both existing and new Customers continue to leverage our Integrated Health PlatformTM.
      • 56% of new direct Members signed up for two services or more in the fourth quarter of 2021. Combined with current Customer expansions, the cumulative number of direct Members with two or more services is now 21%, compared to 14% at the same time last year and 17% at the end of the third quarter of 2021.
      • Average Monthly Net Retention Rate ("NRR") was 102% for the fourth quarter of 2021, marking another quarter of NRR greater than 100%, with no member churn within our mid-market and enterprise customer categories.
      • Gross Margin increased to 43.5%, compared to 34.8% in the fourth quarter of 2020, as the lower margin profile at Optima was more than offset by a favourable utilization rate and by greater scale year-over-year in both our Mental Health service and Employee Assistance Program ("EAP").
      • Adjusted EBITDA1 loss was $5.7 million, compared to a net loss of $5.2 million in the same period last year. The loss was due mainly to higher operating expenses year-over-year to support our growth, to launch and promote new services, to develop our technology platform, and to sustain a public company structure, partially offset by higher gross profit.
      • Net loss was $7.1 million, as compared to $6.6 million in the same period last year, due mainly to higher operating expenses, partially offset by higher gross profit.
      • Cash and Cash Equivalents were $104.3 million as of December 31, 2021, compared to $42.1 million as of December 31, 2020. The increase was the result of net proceeds from the initial public offering of $90.6 million, offset in part by cash used in operations during the year.

      Q4 2021 Business Highlights

      • Building on the launch of our iCBT service in Q3, we developed an enhanced option, iCBT Plus, with guidance from a coach, allowing clients and members to select their desired level of support and autonomy to improve mental health.
      • We rolled out three new self-care toolkits in November within our iCBT program to provide members with an even more robust coverage. In addition to the original modules for managing Depression and Anxiety, eligible Dialogue members can now access toolkits for Social Anxiety, Divorce & Separation, and Loss & Bereavement.
      • On December 1, 2021, we received a meaningful vote of confidence from our largest partner, Sun Life Assurance Company of Canada ("Sun Life"), which increased its investment in Dialogue by acquiring approximately 6 million shares in a private agreement with certain third parties. We did not receive any proceeds from this transaction.
      • On December 2, 2021, we announced an agreement with Canada Life to make our iCBT program available to all Consult+ users across Canada, expanding on its existing Primary Care offering and demonstrating the appeal of our Integrated Health PlatformTM.
      • Subsequent to quarter end, on January 11, 2022, we published our 2nd annual Canadian Attitudes on Health and Virtual Care Report, a joint study with Environics Research. Key findings indicate that 82% of working Canadians agree that employers should provide virtual care services through their benefit plans, and nearly 40% plan to use their employee benefits to help them reach their health and wellness objectives.
      • Subsequent to quarter end, on February 9, 2022, we announced an expanded partnership with Sun Life, whereby both our EAP and iCBT services would be added to the Lumino Health Virtual Care platform effective June 1, 2022.
      • We added Jennifer Buckley to our leadership team as Senior Vice President, Commercial. She most recently held the role of Vice President of Sales and Country Manager for Canada with Workday.
      • We have been ranked #8 on Deloitte's 2021 Canada Technology Fast 50, a program that celebrates the world-class achievements and the evolution of the Canadian technology sector, with a three-year revenue growth of 4,215%

      Upcoming events

      • Laurentian Bank Securities 9th Annual Institutional Investor Conference on April 7, 2022.
      • RBC Capital Markets 2022 Global Healthcare Conference in New York City on May 17-18, 2022.
      • CIBC Capital Markets Technology and Innovation Conference 10.0 in Toronto on May 25-26, 2022.
      • National Bank Financial 12th Annual Quebec Conference in Toronto on June 9, 2022.

      Notice of Conference Call

      Dialogue will host a live video webinar on Wednesday, March 23, 2022 at 9:00 a.m. ET to discuss its financial results. Cherif Habib, CEO, and Navaid Mansuri, CFO, will co-chair the call. All interested parties can join the event at the following link, which is also available in the Events and Presentations section of the Company's website. The presentation will be accompanied by slides, which will be available on the screen view and will be made available prior to the start of the webinar on  the Company's website. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download of Zoom that may be required to attend the event. Listeners that prefer to dial in by phone may do so by accessing the same web link and the dial in details will be provided by email upon registration.

      Non-International Financial Reporting Standards ("IFRS") Financial Measures

      This press release makes reference to certain non-IFRS measures, such as "EBIT" represents net profit or loss before net financing (income) expenses and income taxes,  "EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, and amortization of right-of-use assets) and "Adjusted EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, amortization of right-of-use assets, transaction costs, acquisition costs, change in fair value of conversion feature, share-based payments expense, change in fair value of contingent consideration, severance costs, and foreign exchange gain or loss). These measures are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information as reported under IFRS. Management also believes that other users, such as securities analysts, investors and other interested parties, frequently use non-IFRS measures, particularly in the evaluation of issuers.

      Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Where applicable, we provide a clear quantitative reconciliation from the non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS.

      The following table reconciles net loss to Adjusted EBITDA loss for the three months and years ended December 31, 2021 and 2020:


      DIALOGUE HEALTH TECHNOLOGIES INC.
      ADJUSTED EBITDA
      FOR THE THREE MONTHS AND YEARS ENDED DECEMBER 31, 2021 and 2020


      (in thousands of CAD)


      Three months ended

      December 31,


      Year ended

      December 31,



      2021


      2020


      2021


      2020



      $


      $


      $


      $










      Net loss


      (7,142)


      (6,565)


      (251,352)


      (20,904)

      Net financing (income) 
           expenses


      (207)


      219


      (362)


      714

      Current income tax expense


      36


      —


      70


      —

      Deferred income tax recovery


      (114)


      (229)


      (393)


      (229)

      EBIT


      (7,427)


      (6,575)


      (252,037)


      (20,419)

      Depreciation of property and 
           equipment


      172


      140


      519


      676

      Amortization of intangible 
           assets


      377


      447


      1,502


      740

      Amortization of right-of-use 
           assets


      152


      134


      600


      505

      EBITDA


      (6,726)


      (5,854)


      (249,416)


      (18,498)

      Share-based payments expense


      677


      383


      2,061


      966

      Acquisition costs


      150


      350


      380


      590

      Change in fair value of
           conversion feature


      —


      (104)


      225,417


      (381)

      Fair value of contingent liability


      193


      —


      193


      —

      Severance


      37


      —


      37


      —

      Foreign exchange loss (gain)


      —


      —


      87


      —

      Adjusted EBITDA


      (5,669)


      (5,225)


      (21,241)


      (17,323)

      About Dialogue

      Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

      Forward-Looking Information

      This release includes "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking information may relate to our financial outlook (including revenues and Adjusted EBITDA), and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives.

      In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as "plans" "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

      Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Dialogue as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under "Risk Factors" in the Company's latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities in Canada, all of which are available under the Company's SEDAR profile at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Dialogue. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Dialogue undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws.

      Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not currently known to us or that we currently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information. The forward-looking information represents our expectations as of the date of this earnings release (or as the date it is otherwise stated to be made) and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. All of the forward-looking information contained in this earnings release is expressly qualified by the foregoing cautionary statements.

      DIALOGUE HEALTH TECHNOLOGIES INC.


      CONSOLIDATED STATEMENT OF NET LOSS AND OTHER COMPREHENSIVE INCOME
      FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020



      Three months ended

      December 31,


      Year ended

      December 31,


      2021


      2020


      2021


      2020


      $


      $


      $


      $









      Revenue

      18,916,275


      13,450,370


      68,049,313


      35,801,572

      Cost of services

      10,693,090


      8,774,648


      39,242,644


      21,408,622

      Gross profit

      8,223,185


      4,675,722


      28,806,669


      14,392,950









      Operating expenses








      General and administrative

      8,362,041


      6,679,882


      32,149,578


      20,078,952

      Sales and marketing

      3,363,330


      2,859,778


      11,700,157


      9,432,924

      Product and development

      3,248,270


      1,430,930


      9,515,466


      4,715,248

      Share-based payments expense

      676,741


      382,701


      2,060,636


      966,206


      15,650,382


      11,353,291


      55,425,837


      35,193,330









      Operating loss

      (7,427,197)


      (6,677,569)


      (26,619,168)


      (20,800,380)









      Other expenses








      Change in fair value of conversion 
           feature

      —


      (103,610)


      225,416,590


      (380,526)

      Net financing (income) expenses

      (207,085)


      219,218


      (362,138)


      713,897


      (207,085)


      115,608


      225,054,452


      333,371









      Net loss before income taxes

      (7,220,112)


      (6,793,177)


      (251,673,620)


      (21,133,751)

      Current income tax (expense)

      (35,552)


      —


      (70,466)


      —

      Deferred income tax recovery

      113,968


      229,241


      392,698


      229,241

      Net loss

      (7,141,696)


      (6,563,936)


      (251,351,388)


      (20,904,510)

















      Other comprehensive income















      Items that may be reclassified 
           subsequently to net loss







      Foreign currency translation gain (loss)

      217,971

      (93,871)


      752,499


      (375,481)









      Total comprehensive loss

      (6,923,725)


      (6,657,807)


      (250,598,889)


      (21,279,991)









      Loss per share - basic and diluted

      (0.11)


      (0.59)


      (4.48)


      (1.87)

      DIALOGUE HEALTH TECHNOLOGIES INC.


      CONSOLIDATED STATEMENT OF FINANCIAL POSITION
      AS AT DECEMBER 31, 2021 AND DECEMBER 31, 2020



      December 31,


      December 31,


      2021


      2020


      $


      $

      Assets




      Current assets




      Cash and cash equivalents

      104,296,162


      42,067,100

      Trade and other receivables

      13,659,453


      11,358,615

      Asset held for sale

      —


      909,541

      Prepaid expenses

      1,811,159


      745,673


      119,766,774


      55,080,929





      Property and equipment

      1,136,558


      1,019,406

      Right-of-use assets

      1,567,985


      1,687,434

      Intangible assets

      5,818,624


      5,472,196

      Goodwill

      6,962,820


      3,114,927


      135,252,761


      66,374,892

      Liabilities




      Current liabilities




      Trade payable and accrued liabilities

      9,533,670


      7,489,083

      Unearned revenue

      67,759


      476,619

      Liability related to asset held for sale

      —


      430,110

      Current portion of contingent consideration payable

      718,133


      1,379,501

      Current portion of long-term debt

      400,020


      398,020

      Current portion of lease liabilities

      540,894


      524,618


      11,260,476


      10,697,951





      Non-current portion of lease liabilities

      911,337


      1,086,720

      Non-current portion of long-term debt

      1,074,053


      1,459,407

      Non-current portion of contingent consideration payable

      1,299,907


      523,499

      Redeemable Class B preferred shares

      —


      82,805,661

      Deferred income tax liability

      766,263


      976,890

      Conversion option on redeemable Class B preferred shares

      —


      92,755


      15,312,036


      97,642,883

      Commitments and contingencies








      Shareholders' equity (deficit)




      Share capital

      458,961,698


      18,890,120

      Equity reserve

      3,513,934


      1,777,907

      Cumulative translation adjustment

      347,336


      (405,163)

      Deficit

      (342,882,243)


      (51,530,855)


      119,940,725


      (31,267,991)


      135,252,761


      66,374,892

      DIALOGUE HEALTH TECHNOLOGIES INC.


      CONSOLIDATED STATEMENT OF CASH FLOWS
      FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020



      Year ended

      December 31,


      2021


      2020


      $


      $

      Operating activities




      Net loss

      (251,351,388)


      (20,904,510)

      Items not affecting cash




      Decrease in contingent consideration- Optima

      (358,000)


      —

      Increase in contingent consideration- EHH

      192,688


      —

      Write-off of leasehold improvements

      —


      157,715

      Income tax recovery

      (392,698)


      —

      Change in conversion feature on preferred shares

      225,416,590


      —

      Depreciation of property and equipment

      519,122


      675,830

      Amortization of right-of-use assets

      599,846


      504,956

      Net financing (income) expenses

      (362,138)


      713,897

      Amortization of intangible assets

      1,502,339


      739,873

      Share-based payments

      2,060,636


      966,206


      (22,173,003)


      (17,146,033)

      Net changes in non-cash operating working capital items




      Trade and other receivables

      (2,300,838)


      (7,112,797)

      Prepaid expenses

      (1,065,486)


      (151,766)

      Trade and other payables

      2,044,587


      5,615,788

      Unearned revenue

      (408,860)


      447,369

      Interest paid

      (128,265)


      (64,615)

      Interest income

      752,868


      —


      (23,278,997)


      (18,412,054)





      Investing activities




      Purchase of property and equipment

      (651,026)


      (780,767)

      Purchase of intangible assets

      (86,984)


      (161,140)

      Sale of asset held for sale

      909,541


      —

      Acquisition of Optima

      —


      (5,000,000)

      Acquisition of Botfront

      (291,800)


      —

      Acquisition of e-Hub Health Pty Ltd., net of cash acquired

      (3,137,531)


      —

      Payment of Optima Global Health Inc. Earnout

      (1,500,000)


      —

      Payment of Botfront Earnout

      (198,500)


      —


      (4,956,300)


      (5,941,907)

      Financing activities




      Issuance of shares

      100,008,000


      43,235,247

      Share issue costs

      (9,371,189)


      —

      Options exercised

      603,995


      —

      Repayment of liability related to asset held for sale

      (430,110)


      —

      Repayment of long-term debt

      (400,020)


      (133,330)

      Repayment of lease liabilities

      (698,816)


      (417,271)

      Transaction costs

      —


      (500,000)


      89,711,860


      42,184,646

      Effect of foreign currency translation

      752,499


      (375,481)

      Net increase in cash and cash equivalents

      62,229,062


      17,455,205

      Cash and cash equivalents, beginning of the year

      42,067,100


      24,611,895

      Cash and cash equivalents, end of the year

      104,296,162


      42,067,100

      SOURCE Dialogue Health Technologies Inc.

      Investor relations: Jean Marc Ayas, Director, Investor Relations, [email protected]; Media Relations: Jean-Christophe de Le Rue, Director, Public and Government Relations, [email protected] / 613-806-0671

      Modal title

      Profil de l'entreprise

      Dialogue Health Technologies Inc.

        Autres communiqués de la compagnie

      • Dialogue lance le Profil de Santé pour aider les Canadiens à comprendre leurs risques de santé et à agir

      • Le bien-être des employés canadiens continue de décliner alors que les employeurs peinent à mesurer et à améliorer les résultats

      • Une étude révèle que les soins virtuels de santé mentale financés par l'employeur pourraient faire économiser 22 milliards de dollars par année au Canada

      Communiquer avec PR Newswire

      • 877-269-7890
        De 7 h 30 à 18 h 30 (HE)
      • Devenir un client
      • Demander une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux mondiaux

      Produits

      • Découvrez la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifiez le contenu
      • Relations investisseurs

      À propos

      • À propos de Cision
      • Carrières
      • Énoncé d'accessibilité

      Services

      • Toutes les nouvelles
      • Connexion à la plateforme
      • mon CNW
      • Protection des données

      Ne pas vendre ou partager mes informations personnelles:

      • Soumettre à [email protected] 
      • Appelez gratuitement notre département de la protection de la vie privée: 877-297-8921

      Communiquer avec Cision

      Produits

      À propos

      Services
      • Toutes les nouvelles
      • Comms Cloud Nouvelle Génération
      • Cision Communications Cloud®
      • Plateforme
      • mon CNW
      877-269-7890
      de 8h00 à 22h00
      • Modalités d'utilisation
      • Politique sur la sécurité des données
      • Plan du site
      • Paramètres de cookies
      • Énoncé d'accessibilité
      © Groupe CNW Ltée 2026 Tous droits réservés. Une société Cision.